tlooto
Sign up
SCIEQ3

Clinical Pharmacology in Drug Development

WILEY

Clinical Pharmacology in Drug Development is an academic journal published by WILEY. Identifiers: ISSN 2160-7648, eISSN 2160-7648. Indexed in SCIE. Metrics: JIF 1.8. Subject areas: PHARMACOLOGY & PHARMACY. tlooto lists 1,560 papers from this journal.

CiteScore

-

Scopus citation metric

SJR

-

SCImago rank

SNIP

-

Source normalized impact

Percentage rank

-

JIF percentile rank

Journal profile

ISSN
2160-7648
eISSN
2160-7648
Abbreviation
CLIN PHARM DRUG DEV
Publisher
WILEY
Country
-

Web of Science categories

SCIEPHARMACOLOGY & PHARMACY

Scopus ASJC categories

No ASJC category data available.

Keywords

Pharmacology & Pharmacy

Papers in this journal

Recent papers

  1. From Reflection to Acceleration: Clinical Pharmacology’s 2025 Lessons and 2026 Opportunities

    2026

  2. A comparative pharmacokinetic evaluation of two aqueous progesterone 25 mg injections in healthy postmenopausal women under fasting conditions: An open‐label, balanced, randomized, two‐treatment, two‐period, two‐sequence, single‐dose, crossover bioequivalence study

    2026 · 1 citations

  3. Pharmacokinetics and Safety of VV116 in Subjects With Mild or Moderate Hepatic Impairment Compared With Healthy Controls: A Phase I, Open‐Label Study

    2026

  4. The Triple‐Agonist Revolution: Retatrutide and the Paradigm Shift in Multi‐Hormonal Pharmacotherapy for Obesity and Cardiometabolic Comorbidities

    2026 · 3 citations

  5. Ethnic Bridging of Votoplam, a HTT Gene Splicing Modifier, Using Pharmacokinetic Comparison Between Caucasian and Japanese Subjects.

    2026

Most cited papers

  1. A Phase 1, Open‐Label, Pharmacokinetic Trial to Investigate Possible Drug‐Drug Interactions Between Clobazam, Stiripentol, or Valproate and Cannabidiol in Healthy Subjects

    2019 · 179 citations

  2. Bioavailability and Safety of the Factor Xa Inhibitor Edoxaban and the Effects of Quinidine in Healthy Subjects

    2013 · 146 citations

  3. Empagliflozin (BI 10773), a Potent and Selective SGLT2 Inhibitor, Induces Dose‐Dependent Glucosuria in Healthy Subjects

    2013 · 135 citations

  4. Pharmacokinetic Assessment of Drug‐Drug Interactions of Isavuconazole With the Immunosuppressants Cyclosporine, Mycophenolic Acid, Prednisolone, Sirolimus, and Tacrolimus in Healthy Adults

    2016 · 125 citations

  5. Pharmacokinetic Evaluation of CYP3A4‐Mediated Drug‐Drug Interactions of Isavuconazole With Rifampin, Ketoconazole, Midazolam, and Ethinyl Estradiol/Norethindrone in Healthy Adults

    2016 · 103 citations